Immune System Antibody Mutations Explained

The team of scientists at the Montreal Clinical Research Institute (IRCM), led by Javier Di Noia.
Photo Credit: IRCM

Scientific Frontline: Extended "At a Glance" Summary: Immune System Targeting of Antibody Mutations

The Core Concept: B cells modify their own DNA using the mutagenic enzyme activation-induced cytidine deaminase (AID) to produce a vast diversity of antibodies, a process guided safely by the proteins MLLT1 and MLLT3.

Key Distinction/Mechanism: Unlike uncontrolled genome mutation, the proteins MLLT1 and MLLT3 recognize specific chemical marks on histones and form microscopic molecular condensates; these compartments physically concentrate the naturally inefficient AID enzyme exactly where it is needed, largely sparing the rest of the genome from damage.

Major Frameworks/Components:

• Activation-induced cytidine deaminase (AID): An essential but potentially dangerous enzyme that introduces mutations into antibody genes to improve immune effectiveness.
• MLLT1 and MLLT3 proteins: Histone readers that act as gatekeepers to direct and control AID activity.
• Molecular condensates: Tiny compartments formed by MLLT1 and MLLT3 that gather AID locally to increase the likelihood of targeted mutation.
• Histones: The structural proteins around which DNA is wrapped, providing the chemical markers recognized by the gatekeeper proteins.

University of Queensland: SFL Spotlight

The University of Queensland (UQ), located primarily in Brisbane, functions as a central hub within the Australian scientific and educational infrastructure. Established in the early twentieth century as a "people's university," the institution currently manages a highly distributed physical footprint designed to optimize specific scientific disciplines. This footprint extends from the heritage-listed Helidon sandstone architecture of the St Lucia campus to highly specialized regional facilities, including the 1,068-hectare Gatton campus dedicated to agricultural and veterinary sciences, and clinical biomedical precincts at Herston and Dutton Park.